Table 1 |
|||||
|
Serological features of human and mouse anti-Su sera |
|||||
|
IIF |
K562 cell extract IP |
TnT IP |
|||
|
|
|||||
|
Sera |
GWB foci |
100/102-kDa Su |
200-kDa Su |
hAgo2 |
Dicer |
|
|
|||||
|
Human anti-Su (n = 22) |
91% |
100% |
82% |
91% |
36% |
|
Mouse anti-Su (n = 7) |
100% |
100% |
100% |
100%a |
0%b |
|
Human anti-GW182 (n = 2) |
100% |
50% |
50% |
50% |
100% |
|
Human autoimmune non-anti-Su (n = 10) |
0% |
0% |
0% |
0% |
0%c |
|
Normal human (n = 10) |
0% |
0% |
0% |
0% |
0%c |
|
Pre-immune mouse (n = 6) |
0% |
0% |
0% |
0%c |
0%d |
|
|
|||||
|
an = 5, bn = 2, cn = 4, dn = 1. GWB, GW body; IIF, indirect immunofluorescence of HEp-2 cells; IP, immunoprecipitation; TnT, in vitro transcription and translation. |
|||||
|
Jakymiw et al. Arthritis Research & Therapy 2006 8:R87 doi:10.1186/ar1959 |
|||||